Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance.
Sign Up to like & getrecommendations! Published in 2020 at "Drug discovery today"
DOI: 10.1016/j.drudis.2020.12.016
Abstract: Cancer cell resistance to chemotherapeutics (chemoresistance) poses a significant clinical challenge that oncology research seeks to understand and overcome. Multiple anticancer drugs and targeting agents can be incorporated in nanomedicines, in addition to different treatment… read more here.
Keywords: chemoresistance; driven molecular; molecular targeting; drug ... See more keywords